Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Anette

Anette Aesoy, Skien NO

Patent application numberDescriptionPublished
20090242468System for Controlling the Concentration of a Detrimental Substance in a Sewer Network - The invention relates to a system for controlling the concentration of a detrimental substance, in particular H10-01-2009

Anette Berni, Kashofen DE

Patent application numberDescriptionPublished
20090141359PLASTIC FILM WITH A MULTILAYERED INTERFERENCE COATING - A polymer film with an optical interference system. The optical interference system comprises at least two layers of different refractive index, which layers comprise nanoscale inorganic particles having organic surface groups that are polymerizable and/or polycondensable. The layers are at least partially crosslinked through the organic surface groups.06-04-2009

Anette Brunner-Schwarz, Frankfurt DE

Patent application numberDescriptionPublished
20090082255Acidic Insulin Preparations Having Improved Stability - The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.03-26-2009
20100216692Acidic Insulin Preparations Having Improved Stability - The invention relates to a pharmaceutical formulation comprising a polypeptide selected from the group consisting of insulin, an insulin metabolite, an insulin analog, an insulin derivative and combinations thereof; a surfactant or combinations of two or more surfactants; optionally a preservative or combinations of two or more preservatives; and optionally an isotonicizing agent, buffers or further excipients or combinations thereof, the pharmaceutical formulation having a pH in the acidic range.08-26-2010

Patent applications by Anette Brunner-Schwarz, Frankfurt DE

Anette Gundertofte, Frederiksberg DK

Patent application numberDescriptionPublished
2010012074311Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds - A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.05-13-2010

Anette Heijnesson-Hulten, Lerum SE

Patent application numberDescriptionPublished
20100112351METHOD FOR PREPARING MICROFIBRILLAR POLYSACCHARIDE - The present invention relates to a method of preparing microfibrillar polysaccharide comprising treating a polysaccharide in an aqueous suspension comprising an oxidant and at least one transition metal, mechanically delaminating said polysaccharide such that microfibrillar polysaccharide is formed. The invention also relates to microfibrillar polysaccharide obtainable by the method.05-06-2010

Anette Høj, Tjele DK

Patent application numberDescriptionPublished
20100099104GENETIC TEST FOR THE IDENTIFICATION OF CARRIERS OF COMPLEX VERTEBRAL MALFORMATIONS IN CATTLE - Genetic markets for identifying bovine carriers of complex vertebral malformation (CVM) disease gene are described. The genetic markers, including the microsatellite markers, BM4129, INRAA003, BMS2790, ILSTS029, INRA123, BM220, HUJ246, BMS862, BMS937, BL1048, BMS2095 and BMS1266 and the bovine SLC35A3 gene, are located on bovine chromosome BTA3. The G/T polymorphism at position 559 of the bovine SLC35A3 gene is identified as being causative and diagnostic for CVM in cattle.04-22-2010

Anette Holtmann, Ballerup DK

Patent application numberDescriptionPublished
20090143232METHOD FOR SYNTHESISING TEMPLATED MOLECULES - The invention relates to a method for synthesizing templated molecules attached to the templated which directed the synthesis thereof. The method involves a template, a scaffold functional entity and a functional entity attached to a building block, which, in turn, is attached the template. The scaffold functional entity and the functional entity of the building block are both provided with complementary dimerization domains allowing the functional entities to come into close proximity when the complementary domains interact with to each other. The method may be used for generating libraries of templated molecules which may be selected for biological activity.06-04-2009
20090264300ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES - Disclosed is a method for obtaining a bifunctional complex comprising a molecule linked to a single stranded identifier oligonucleotide, wherein a nascent bifunctional complex comprising a chemical reaction site and a priming site for enzymatic addition of a tag is a) reacted at the chemical reaction site with one or more reactants, and b) reacted enzymatically at the priming site with one or more tag(s) identifying the reactant(s).10-22-2009
20100016177TEMPLATED MOLECULES AND METHODS FOR USING SUCH MOLECULES - The present invention relates to a method for synthesising templated molecules. In one aspect of the invention, the templated molecules are linked to the template which templated the synthesis thereof. The intion allows the generation of libraries which can be screened for e.g. therapeutic activity.01-21-2010
20110230419IAP BINDING COMPOUNDS - The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, solvates or prodrugs thereof, that bind to Inhibitor of Apoptosis Proteins (IAPs). The compounds of the invention may be used as diagnostic and therapeutic agents in the treatment of proliferative diseases, such as cancer, for promoting apoptosis in proliferating cells, and for sensitizing cells to inducers of apoptosis. The present invention furthermore provides a polymeric compound of formulas (VI) or (VII), comprising either at least two monomeric units of compounds of formula (I), or at least one monomeric unit of a compound of formula (I) and an entity E. The present invention further relates to pharmaceutical compositions comprising said compounds of formulas (I), (VI), and (VII) and the use of said compounds in medicine.09-22-2011

Patent applications by Anette Holtmann, Ballerup DK

Anette Koenigsdorfer, Ilvesheim DE

Patent application numberDescriptionPublished
20080292642Crystalline anti-human IL-12 antibodies - The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.11-27-2008
20100034823Crystalline anti-hTNFalpha antibodies - The present invention relates to a batch crystallization method for crystallizing an anti-hTNFalpha antibody which allows the production of said antibody on an industrial scale; antibody crystals as obtained according to said method; compositions containing said crystals as well as methods of use of said crystals and compositions.02-11-2010

Anette Nordskog, Sandefjord NO

Patent application numberDescriptionPublished
20100024133TRIS(HETEROCYCLYL) METAL COMPLEXES, WASHING AND CLEANING AGENTS CONTAINING THE SAME, AND USE AS BLEACH CATALYSTS - Tris(heterocyclyl)-metal complexes and the use thereof as bleach catalysts are described.02-04-2010
20100029540BIHETEROARYL METAL COMPLEXES AS BLEACH CATALYSTS - Biheteroaryl metal complexes and the use thereof as bleach catalysts are described.02-04-2010
20100048447BIS(HYDROXYQUINOLINE) METAL COMPLEXES AS BLEACH CATALYSTS - Bis(hydroxyquinoline)-metal complexes and the use thereof as bleach catalysts are described.02-25-2010
20110119837Washing Agent That Is Gentile on Textiles - Reduction of damage to textiles caused when bleach active catalysts are used when washing the textiles, without influencing bleaching performance. The invention relates to a method for washing textiles in the presence of a peroxygenated bleaching agent and a bleach boosting transition metal complex, wherein the method is carried out when water hardness is between 0° dH-3° dH.05-26-2011

Anette Nordskog, Duesseldorf DE

Patent application numberDescriptionPublished
20090156454GRANULATES FOR A SENSITIVE WASHING- OR CLEANING AGENT CONTAINING MATERIAL - Granulates for washing- or cleaning agents, containing (a) a sensitive washing- or cleaning agent component, (b) an adsorbent carrier material, (c) a binder that is different from (b), and (d) optional additional substances that are different from (b) and (c). The granulates display a disintegration index of at least 50 percent after 24 hours. These granulates are particularly suited for use in liquid- or gel-forming aqueous washing- or cleaning agents. Also, a procedure for the manufacture of such granulates, in regards to washing- or cleaning agents.06-18-2009

Anette Partheil, Darmstadt DE

Patent application numberDescriptionPublished
20110113867DEVICE FOR RECEIVING A SOLID IN A MEASURING CELL - A device for the accommodation of a solid in a measuring cell (05-19-2011

Anette Sallwey, Dreieich DE

Patent application numberDescriptionPublished
20110311465Oxidizing Composition for the Treatment of Keratin Fibers - The present invention relates to an oxidizing composition for treatment of keratin fibers comprising a combination of; (a) at least one anionic associative copolymer, (b) at least one anionic non associative copolymer; (c) at least one peroxide agent; (d) at least one persulfate agent; (e) at least on alkalizing agent; and (f) a carrier medium suitable for hair treatment.12-22-2011

Anette Sandegard, Malmo SE

Patent application numberDescriptionPublished
20080287060Electronic Equipment for a Wireless Communication System and Method for Operating an Electronic Equipment for a Wireless Communication System - The present invention relates to an electronic equipment for a wireless communication system comprising a near field interface (11-20-2008

Anette Sommer, Berlin DE

Patent application numberDescriptionPublished
20090076098METHODS, KITS, AND COMPOUNDS FOR DETERMINING RESPONSIVENESS TO TREATMENT OF A PATHOLOGICAL DISORDER BY EPOTHILONES - The invention provides methods, kits and compounds for determining the potential responsiveness of a subject suffering from a pathological disorder, including non-small cell lung cancer (NSCLC), to treatment with an epothilone by analyzing the gene expression profile and/or certain molecular markers in a sample obtained from said subject. The invention further relates to methods, compounds and uses of said compounds for treating subjects suffering from said pathologic disorder, optionally in combination with other therapeutic agents. Also provided are genes and/or proteins encoded by them whose expression level have been determined to differ between epothilone responders and epothilone non-responders.03-19-2009

Anette Stryhn, Virum DK

Patent application numberDescriptionPublished
20110020384THERAPEUTIC TB VACCINE - Therapeutic vaccines comprising polypeptides expressed during the latent stage of mycobacteria infection are provided, as are multiphase vaccines, and methods for treating and preventing 01-27-2011

Anette Thyberg, Stenungsund SE

Patent application numberDescriptionPublished
20090076299PHOSPHATED ALCANOL, ITS USE AS A HYDROTROPE AND CLEANING COMPOSITION CONTAINING THE COMPOUND - The present invention relates to the use of phosphated 2-propylheptanol or a phosphated 2-propylheptanol alkoxylate as a hydrotrope in aqueous alkaline solutions for a C03-19-2009

Anette Weyergang, Oslo NO

Patent application numberDescriptionPublished
20110293575PHOTOCHEMICAL INTERNALISATION OF KINASE INHIBITORS - The present invention relates to a method for enhancing the activity of kinase inhibitors in target cells, and more specifically for enhancing the activity of tyrosine kinase inhibitors (TKIs), said method comprising contacting a cell with a kinase inhibitor and a photosensitizing agent and irradiating said cell with light of a wavelength effective to activate the photosensitizing agent, and to the use of this method for enhancing the effects of kinase inhibitors or kinase inhibitor-based drugs in particular to achieve cell death, for example, in cancer treatment and other diseases or conditions in which kinase inhibitors, such as TKIs, have a beneficial effect.12-01-2011

Anette Zur Mühlen, Krefeld DE

Patent application numberDescriptionPublished
20100288792DISPENSER, IN PARTICULAR, METERING DISPENSER - The invention concerns a dispenser, in particular for semi-solid or liquid systems, with a housing to hold a dispenser unit which is formed by a storage container, a metering unit (11-18-2010

Anette Zur Mühlen, Krefeld DE

Patent application numberDescriptionPublished
20100288792DISPENSER, IN PARTICULAR, METERING DISPENSER - The invention concerns a dispenser, in particular for semi-solid or liquid systems, with a housing to hold a dispenser unit which is formed by a storage container, a metering unit (11-18-2010